Patricia Carr - 17 Jan 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
SVP, Chief Accounting Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Patricia Carr
Issuer symbol
JAZZ
Transactions as of
17 Jan 2025
Net transactions value
$0
Form type
4
Filing time
22 Jan 2025, 18:46:35 UTC
Previous filing
04 Dec 2024
Next filing
03 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +1,641 +25% $0.000000 8,237 17 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified.